Last reviewed: July 3, 2026
Last updated: July 3, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injections deliver powerful weight loss results by activating GLP-1 receptors in your brain and digestive tract, but successful treatment depends on correct injection placement. Understanding where and how to inject this medication ensures consistent drug delivery, minimizes discomfort, and reduces the risk of injection-site reactions. PlexusDx provides detailed guidance to help patients master self-administration with confidence.
Approved Injection Sites for Semaglutide Administration
Semaglutide can only be injected into subcutaneous tissue—the layer of fat beneath your skin but above muscle. The three approved injection sites are the abdomen, thigh, and upper arm. Each area contains enough subcutaneous fat to safely accommodate the needle and medication. The abdomen remains the most commonly used site because it offers a large, accessible surface area and consistent absorption patterns. Many patients find abdominal injections easier to self-administer without assistance.
The thigh presents an equally valid option, particularly the outer thigh between hip and knee. This location allows for easy accessibility and can be injected while sitting or standing. The upper arm, specifically the back of the upper arm near the triceps, serves as a third choice for patients who prefer variety. All three sites have been validated in clinical trials and provide reliable drug absorption when proper injection technique is followed. Rotating between these locations helps prevent tissue damage and lipodystrophy over long-term treatment.
How to Rotate Injection Sites Properly
Site rotation prevents the development of lipodystrophy—permanent changes in fat tissue that can affect medication absorption and create cosmetic concerns. A systematic rotation strategy involves selecting multiple injection points within each approved area rather than injecting in the exact same spot repeatedly. If using the abdomen, divide it into quadrants and select a different quadrant each week. This distributes trauma across a larger tissue area and allows each location time to heal between injections.
Within each quadrant or anatomical region, space injections at least one finger-width apart from previous injection sites. A practical rotation schedule might involve injecting the abdomen for weeks one through four, then switching to the thigh for weeks five through eight, followed by the upper arm for weeks nine through twelve. After completing this twelve-week cycle, return to the first site, which has had adequate recovery time. Document your injection sites using a simple log or calendar to ensure consistent rotation and prevent accidentally re-injuring tissue that hasn't fully healed.
Step-by-Step Injection Technique for Safe Administration
Begin by washing your hands thoroughly with soap and water and allowing them to dry completely before handling your medication. Remove the semaglutide pen or syringe from the refrigerator and allow it to sit at room temperature for fifteen minutes—cold medication causes more discomfort upon injection. Inspect the medication for particles, cloudiness, or discoloration; it should appear clear and colorless. Select your injection site and clean the skin with an alcohol swab in a circular motion, expanding outward from the center. Allow the alcohol to air-dry for thirty seconds before proceeding.
Gently pinch the skin at your chosen injection site to create a fold of subcutaneous tissue. Hold the pen or syringe at a ninety-degree angle to your skin and insert the needle smoothly through the pinched skin. Release the pinched skin once the needle is fully inserted, then depress the plunger or button to deliver the medication. Keep the needle in place for three seconds after injection to allow the full dose to enter the tissue. Remove the needle and immediately apply gentle pressure with a clean cotton ball or gauze pad for five to ten seconds. Do not massage the injection site, as this can affect absorption and increase discomfort.
Managing Injection Site Reactions and Discomfort
Minor redness, swelling, and slight bruising at injection sites are normal and typically resolve within twenty-four to forty-eight hours without intervention. Applying ice for ten minutes immediately after injection can reduce inflammation and discomfort. If you experience persistent redness lasting more than three days, significant swelling, or warmth at the site, contact your healthcare provider to rule out infection. Using smaller gauge needles and allowing medication to reach room temperature before injection significantly reduces needle-related pain and tissue trauma.
Some patients develop lipohypertrophy—localized thickening or hardening of fat tissue—when sites are not rotated properly. This condition causes uneven medication absorption and can impair treatment effectiveness. Avoid injecting into areas of existing lipohypertrophy, as these sites absorb medication unpredictably. If you notice lumps, thickened areas, or skin changes at previous injection sites, immediately expand your rotation schedule to include fresh tissue. PlexusDx patients receive detailed injection training resources to prevent these complications and optimize their treatment experience.
PlexusDx Compounded Semaglutide vs. Brand Alternatives
PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies, delivering the same active ingredient as brand-name Wegovy at significantly lower cost. Compounded formulations undergo rigorous quality testing to ensure sterility, potency, and purity matching pharmaceutical standards. PlexusDx compounded semaglutide injections start at $189/mo (or $149/mo on the 6-month plan) on the base commitment tier, with no insurance requirement and full HSA/FSA eligibility. The medication arrives ready to use with clear administration instructions, allowing patients to begin treatment immediately without prior pharmacy authorization delays.
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide into muscle tissue instead of fat?
No—semaglutide must be injected into subcutaneous tissue (the fat layer under skin) to ensure proper absorption and prevent muscle damage. Intramuscular injection causes pain, inflammation, and unpredictable medication delivery. Always pinch your skin to identify the subcutaneous fat layer before injecting.
How many different injection sites do I need to use?
You should rotate among at least six to eight injection points across the three approved areas (abdomen, thigh, upper arm) to prevent lipodystrophy. A twelve-week rotation schedule using multiple sites within each anatomical region provides optimal tissue recovery and consistent medication absorption throughout your treatment.
What's the difference between PlexusDx compounded semaglutide and brand-name Wegovy?
Both contain identical active semaglutide, but PlexusDx sources from licensed 503A compounding pharmacies at $189/month starting price—significantly lower than brand alternatives. PlexusDx also offers the optional Precision Peptide Genetic Test for $99 to personalize your therapy based on your unique peptide metabolism.
Is bruising or redness after injection normal?
Minor redness and bruising lasting one to two days are normal responses to injection trauma. Persistent redness beyond three days, significant swelling, or warmth may indicate infection and require medical evaluation. Using room-temperature medication and proper rotation techniques minimize these reactions significantly.
How does the Precision Peptide Genetic Test improve my semaglutide results?
No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Much Weight Do You Lose a Month on Wegovy?
Navigating Ozempic Dosing: Can I Split My Dose for Optimal Weight Management?